Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian G Hartinger

Showing results (121-130 of 190) with videos related to

Pageof 19
Sort By:
Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry|November 14, 2023
In vitro and in vivo accumulation of the anticancer Ru complexes [Ru<sup>II</sup>(cym)(HQ)Cl] and [Ru<sup>II</sup>(cym)(PCA)Cl]ClMie Riisom, Stuart J Morrow, Caitlin D Herbert, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|May 11, 2010
An internal fluorescent probe based on anthracene to evaluate cation-anion interactions in imidazolium saltsZhaofu Fei, Dun-Ru Zhu, Xue Yang, et al.
Frontiers in Chemistry|July 26, 2021
Cavity-Containing [Fe<sub>2</sub>L<sub>3</sub>]<sup>4+</sup> Helicates: An Examination of Host-Guest Chemistry and CytotoxicityLynn S Lisboa, Mie Riisom, Roan A S Vasdev, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|May 29, 2013
Identification of the structural determinants for anticancer activity of a ruthenium arene peptide conjugateSamuel M Meier, Maria Novak, Wolfgang Kandioller, et al.
Physical Chemistry Chemical Physics : PCCP|February 11, 2010
Nitrile-functionalized pyrrolidinium ionic liquids as solvents for cross-coupling reactions involving in situ generated nanoparticle catalyst reservoirsYugang Cui, Ilaria Biondi, Manish Chaubey, et al.
Journal of Inorganic Biochemistry|July 30, 2016
Anticancer activity of Ru- and Os(arene) compounds of a maleimide-functionalized bioactive pyridinecarbothioamide ligandMuhammad Hanif, Sally Moon, Matthew P Sullivan, et al.
Journal of Medicinal Chemistry|April 4, 2007
Structure-activity relationships for NAMI-A-type complexes (HL)[trans-RuCl4L(S-dmso)ruthenate(III)] (L = imidazole, indazole, 1,2,4-triazole, 4-amino-1,2,4-triazole, and 1-methyl-1,2,4-triazole): aquation, redox properties, protein binding, and antiproliferative activityMichael Groessl, Erwin Reisner, Christian G Hartinger, et al.
Chemistry & Biodiversity|October 31, 2008
KP1019, a new redox-active anticancer agent--preclinical development and results of a clinical phase I study in tumor patientsChristian G Hartinger, Michael A Jakupec, Stefanie Zorbas-Seifried, et al.
Dalton Transactions (Cambridge, England : 2003)|November 23, 2022
Hydrazone- and imine-containing [PdPtL<sub>4</sub>]<sup>4+</sup> cages: a comparative study of the stability and host-guest chemistryLynn S Lisboa, Mie Riisom, Henry J Dunne, et al.
Electrophoresis|June 9, 2007
Probing the stability of serum protein-ruthenium(III) drug adducts in the presence of extracellular reductants using CEAndrei R Timerbaev, Lidia S Foteeva, Alexander V Rudnev, et al.
Pageof 19

Showing results (121-130 of 190) with videos related to

Sort By:
Pageof 19
Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry|November 14, 2023
In vitro and in vivo accumulation of the anticancer Ru complexes [Ru<sup>II</sup>(cym)(HQ)Cl] and [Ru<sup>II</sup>(cym)(PCA)Cl]ClMie Riisom, Stuart J Morrow, Caitlin D Herbert, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|May 11, 2010
An internal fluorescent probe based on anthracene to evaluate cation-anion interactions in imidazolium saltsZhaofu Fei, Dun-Ru Zhu, Xue Yang, et al.
Frontiers in Chemistry|July 26, 2021
Cavity-Containing [Fe<sub>2</sub>L<sub>3</sub>]<sup>4+</sup> Helicates: An Examination of Host-Guest Chemistry and CytotoxicityLynn S Lisboa, Mie Riisom, Roan A S Vasdev, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|May 29, 2013
Identification of the structural determinants for anticancer activity of a ruthenium arene peptide conjugateSamuel M Meier, Maria Novak, Wolfgang Kandioller, et al.
Physical Chemistry Chemical Physics : PCCP|February 11, 2010
Nitrile-functionalized pyrrolidinium ionic liquids as solvents for cross-coupling reactions involving in situ generated nanoparticle catalyst reservoirsYugang Cui, Ilaria Biondi, Manish Chaubey, et al.
Journal of Inorganic Biochemistry|July 30, 2016
Anticancer activity of Ru- and Os(arene) compounds of a maleimide-functionalized bioactive pyridinecarbothioamide ligandMuhammad Hanif, Sally Moon, Matthew P Sullivan, et al.
Journal of Medicinal Chemistry|April 4, 2007
Structure-activity relationships for NAMI-A-type complexes (HL)[trans-RuCl4L(S-dmso)ruthenate(III)] (L = imidazole, indazole, 1,2,4-triazole, 4-amino-1,2,4-triazole, and 1-methyl-1,2,4-triazole): aquation, redox properties, protein binding, and antiproliferative activityMichael Groessl, Erwin Reisner, Christian G Hartinger, et al.
Chemistry & Biodiversity|October 31, 2008
KP1019, a new redox-active anticancer agent--preclinical development and results of a clinical phase I study in tumor patientsChristian G Hartinger, Michael A Jakupec, Stefanie Zorbas-Seifried, et al.
Dalton Transactions (Cambridge, England : 2003)|November 23, 2022
Hydrazone- and imine-containing [PdPtL<sub>4</sub>]<sup>4+</sup> cages: a comparative study of the stability and host-guest chemistryLynn S Lisboa, Mie Riisom, Henry J Dunne, et al.
Electrophoresis|June 9, 2007
Probing the stability of serum protein-ruthenium(III) drug adducts in the presence of extracellular reductants using CEAndrei R Timerbaev, Lidia S Foteeva, Alexander V Rudnev, et al.
Pageof 19